Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
Roohullah, Aflah; Wong, Hui-Li; Sjoquist, Katrin M; Gibbs, Peter; Field, Kathryn; Tran, Ben; Shapiro, Jeremy; Mckendrick, Joe; Yip, Desmond; Nott, Louise; Gebski, Val; Ng, Weng; Chua, Wei; Price, Timothy; Tebbutt, Niall; Chantrill, Lorraine
AIM To investigate the safety and efficacy of adding bevacizumab to first-line chemotherapy in metastatic colorectal cancer patients with peritoneal disease. METHODS We compared rates of gastrointestinal perforation in patients with metastatic colorectal cancer and peritoneal disease receiving first-line chemotherapy with and without bevacizumab in three distinct cohorts: (1) the AGITG MAX trial (Phase III randomised clinical trial comparing capecitabine vs capecitabine and bevacizumab vs...[Show more]
|Collections||ANU Research Publications|
|Source:||World journal of gastroenterology:WJG|
|Roohullah, A et al Gastrointestinal perforation in metastatic 2015.pdf||886.73 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.